The characterization of enantiomers is an important analytical challenge in the chemical and life sciences. Thorough evaluation of the purity of chiral molecules is particularly required in the pharmaceutical industry where safety concerns are paramount. Assessment of the enantiomeric composition is still challenging and time-consuming, meaning that alternative approaches are required. In this study, we exploit the formation of dimers as diastereomeric pairs of enantiomers to affect separation by high resolution cyclic ion mobility-mass spectrometry. Using the example of (R/S)-thalidomide, we show that even though this is not an enantiomer separation, we can determine which enantiomer is in excess and obtain quantitative information on the enantiomer composition without the need for a chiral modifier. Further examples of the approach are presented, including d/l-tryptophan and (R/S)-propanolol, and demonstrate the need for mobility resolving power in excess of 400 (CCS/ΔCCS).
The characterization of enantiomers is an important analytical challenge in the chemical and life sciences. Thorough evaluation of the purity of chiral molecules is particularly required in the pharmaceutical industry where safety concerns are paramount. Assessment of the enantiomeric composition is still challenging and time-consuming, meaning that alternative approaches are required. In this study, we exploit the formation of dimers as diastereomeric pairs of enantiomers to affect separation by high resolution cyclic ion mobility-mass spectrometry. Using the example of (R/S)-thalidomide, we show that even though this is not an enantiomer separation, we can determine which enantiomer is in excess and obtain quantitative information on the enantiomer composition without the need for a chiral modifier. Further examples of the approach are presented, including d/l-tryptophan and (R/S)-propanolol, and demonstrate the need for mobility resolving power in excess of 400 (CCS/ΔCCS).
Mass spectrometry
(MS) is invaluable
in the detection and quantitation of chemical species. Over the years,
the power of MS has increased with improvements in resolving power,
sensitivity, and speed. A significant leap forward came when researchers
in the late 1990s and early 2000s developed hybrid ion mobility–mass
spectrometry systems that demonstrated great promise in the study
of molecular structure.[1−5] A further advance came in 2006 with the introduction of the first
commercial ion mobility spectrometry–mass spectrometry (IMS-MS)
system,[6] which offered this powerful new
tool to a broad range of scientists. Ion mobility spectrometry separates
ions based on their charge, size, and shape as they are propelled
through an inert buffer gas by an electric field. There are many different
types of ion mobility spectrometry, including drift tube ion mobility
spectrometry (DTIMS),[1−5] trapped ion mobility spectrometry (TIMS),[7] field-asymmetric waveform ion mobility spectrometry (FAIMS),[8] and the focus of this Article, traveling wave
ion mobility spectrometry (TWIMS).[9−11] This latter technique
has been in use for the past two decades on commercial hybrid ion
mobility quadrupole time-of-flight mass spectrometers, including the
recently introduced cyclic TWIMS instrument.[12] TWIMS has also been implemented in the form of custom and commercial
structures for lossless ion manipulation (SLIM)[13] devices. Since its commercial introduction coupled to mass
spectrometry, ion mobility has been used extensively in the chemical,
life, and materials sciences to study molecular structure and has
been particularly powerful in the separation and characterization
of isomers.[14] As they have the same chemical
formulas, isomers often yield identical mass spectra, but can be differentiated
by ion mobility, which measures ions by virtue of the arrangement
of their atoms in three-dimensional space (i.e., configuration and
conformation).Ion mobility has been investigated extensively
for the separation
of optical isomers, that is, enantiomers, but this is only ever possible
after introducing a chiral modifier of some sort to induce some diastereomeric
character, diastereomers being readily separated by ion mobility.[15] There has been an investigation into the separation
of enantiomers by introduction of chiral dopants directly into the
drift region of a DTIMS instrument.[16] While
showing promise, such work has proved difficult to reproduce.[17] More recently, covalent derivatization prior
to mobility analysis has been shown to provide an effective means
to identify and quantify chiral amino acids in milk and other mixtures.[18−21] Particularly interesting is the study of noncovalent chiral modifiers
for the formation of diastereomeric complexes prior to or during electrospray
ionization, which can subsequently be separated by ion mobility.[22−32] A recent study using FAIMS has also characterized protonation-induced
chirality through the formation of chiral centers at tertiary amines,
leading to diastereomeric ions with distinct mobilities.[33]Cyclic ion mobility spectrometry is a
recently introduced technique
that affords high mobility resolving power through the extension of
the separation path length by enabling multiple passes around a cyclic
TWIMS device.[12] It has shown early promise
in the characterization of isomeric species, including oligosaccharides,[34−39] nucleosides,[40] peptides,[41−43] fuels,[44−46] and native proteins.[47,48] In particular,
it is unique in its ability to perform many rounds of mobility separation
punctuated by fragmentation steps, termed IMSn.[12,37] Despite the ultrahigh resolution of cyclic TWIMS and any other ion
mobility technique, it does not enable separation of enantiomers due
to the requirement of a chiral separation environment.In this
study we investigated the separation of enantiomers by
cyclic TWIMS. We observed the formation of dimers for thalidomide
(thal), a model chiral pharmaceutical compound (Figure A). High mobility resolution analysis revealed
two species for the dimers, consistent with the formation of diastereomeric
pairs of enantiomers (Figure B). We set out to confirm the identity of these species and
discovered that the observation of these dimers enabled the determination
of the purity status of thal. Furthermore, the ratio of the mobility-resolved
species could directly report on the amounts of each enantiomer in
the mixture. By extension, therefore, we propose that this method
of studying diastereomeric pairs of enantiomeric dimers could be used
to rapidly estimate the enantiomeric composition of chiral species.
We note that the phenomenon of self-association as a means to glean
information on enantiomeric composition has been previously reported
using achiral liquid chromatography[49,50] and nuclear
magnetic resonance spectroscopy (NMR).[51] Furthermore, MS and IMS-MS have been used to study the structure
and assembly of homo- and heterochiral clusters of the amino acids
proline and serine.[52−61] To our knowledge, however, this report constitutes the first instance
of using ion mobility to determine enantiomeric composition directly,
using only dimers where no chiral modifier is required. We investigated
the generality of the dimerization phenomenon by applying the method
to three other chiral molecules, tryptophan, propranolol and the covalent
dimers of penicillamine disulfide and show that ultrahigh ion mobility
resolution (in excess of 400 (CCS/ΔCCS) is essential for these
experiments.
Figure 1
Enantiomers of thalidomide and their diastereomeric dimers.
(A)
The structures of (R)- and (S)-thalidomide;
(B) Black boxes each contain possible dimers formed in a mixture of
(R)- and (S)-thalidomide, namely
(R,R), (S,S), (R,S), and (S,R). The mixed (R,S/S,R) dimers are degenerate,
but are shown separately here for illustration. Solid arrows denote
pairs of enantiomers, whereas dashed arrows denote pairs of diastereomers.
Enantiomers of thalidomide and their diastereomeric dimers.
(A)
The structures of (R)- and (S)-thalidomide;
(B) Black boxes each contain possible dimers formed in a mixture of
(R)- and (S)-thalidomide, namely
(R,R), (S,S), (R,S), and (S,R). The mixed (R,S/S,R) dimers are degenerate,
but are shown separately here for illustration. Solid arrows denote
pairs of enantiomers, whereas dashed arrows denote pairs of diastereomers.
Experimental Section
Materials
All
molecules studied were purchased from
Merck-Sigma (Gillingham, U.K.) as follows: (R)-thalidomide
(T151), (S)-thalidomide (T150), d-penicillamine
(P4875), l-penicillamine (196312), l-tryptophan
(T8941), d-tryptophan (T9753), (R)-propanolol
(P0689), and (S)-propanolol (P8688).
Sample Preparation
(R)- and (S)-Thalidomide solutions
were prepared gravimetrically to
a stock concentration of 1 mM in a solution of 50:49:1 methanol/acetonitrile/formic
acid (v/v %). The stock solution was diluted to 100 μM with
50:49.9:0.1 methanol/water/formic acid (v/v %) before direct infusion
into the Z-spray ion source at a flow rate of 5 μL/min. Stock
solutions of d-penicillamine and l-penicillamine
were prepared to a concentration of 1 mM in water and diluted to 100
μM with 50:49.9:0.1 methanol/water/formic acid (v/v %) before
direct infusion. l- and d-Tryptophan and (R)- and (S)-propanolol were prepared individually
to stock concentrations of 1 mM in 50:49.9:0.1 water/acetonitrile/formic
acid (v/v %) and diluted to 100 μM in the same solvents prior
to analysis. To simulate racemic mixtures of the compounds, equal
volumes of equimolar stocks of each enantiomer were mixed before ion
mobility–mass spectrometry analysis. When required, stock solutions
of 1 M NaCl or 1 M LiCl were added to final concentrations of 1 mM
to promote sodium and lithium adduct formation.
Ion Mobility–Mass
Spectrometry
All experiments
were performed using a SELECT SERIES Cyclic IMS instrument (Waters
Corporation, Wilmslow, U.K.). For high resolution multipass cyclic
ion mobility analysis the traveling wave pulse height was set to 12
V, with a velocity of 375 m/s. The number of passes was varied by
choosing appropriate “separate” times in the instrument
control software. Pre- and postmobility voltages were minimized to
preserve the dimer complexes throughout the instrument; trap and transfer
collision voltages 4 and 2 V, respectively, post-trap gradient 5 V,
post-trap bias 15 V, helium cell entrance 3 V, helium cell bias 22
V, array pulse height in eject 15 V, and pretransfer gradient 5 V.For TWCCSN2 measurements, a traveling wave
height of 15 V was used with a wave velocity of 375 m/s. The instrument
was CCS-calibrated with a number of ions from the CCS Majormix calibration
standard (Waters part number 186008113), using a power law of the
form y = ax, where a and b are constants
determined by fitting a linear regression to a natural log–log
plot of reduced CCS versus arrival time.[62]
Software and Data Analysis
Data were manually processed
using Masslynx v4.2 (SCN 1016) with TWCCSN2 values
being determined using UNIFI 1.9.4 (both Waters Corp., Wilmslow, U.K.).
For Gaussian fitting of arrival time distributions (ATDs), Microsoft
Excel was used. For the generation of the theoretical “simplistic”
scenarios, the contributions to the peak areas of the two features
were calculated simply by the probabilities of dimer formation from
the known mixing ratio of the two enantiomers (see Supporting Information). As discussed in the Results section, we invoke an empirical “response factor”, F, to adjust the simplistic peak areas to match those in
the experiment.where Ihet and Ihom are the observed experimental
relative peak
areas of the ATDs of the heterodimer and homodimer in the racemic
mixture, respectively. This response factor can then be used to determine
the enantiomer ratio, E.R., for an unknown mixing ratio of enantiomers
usingPlease refer to
the Supporting Information for more details on the derivation.
Results
Cyclic
Ion Mobility of Thalidomide Monomers and Dimers
First, we
acquired a single pass cyclic ion mobility (cIMS) experiment
on a solution of rac-thalidomide to observe which
species were present (Figure ). We detected primarily the protonated form of thalidomide
(thal) at 259 m/z, as well as a
significant proportion of the sodiated form at 281 m/z. We also detected low levels of dimeric species
at 517 m/z and 539 m/z corresponding to protonated and sodiated species,
respectively. These dimers are likely formed as a result of the high
solution concentrations used and the concentration effect afforded
by the electrospray process.[63,64] We note that other
approaches employing noncovalent chiral modifiers use similarly high,[32] if not higher,[30] analyte
concentrations to promote complex formation.
Figure 2
TOF-MS dimension of a
single pass cyclic IMS experiment of racemic
thalidomide. The major ions of interest are indicated on the spectrum,
the predominant species being the [M + H]+ and [M + Na]+ at 259.07 and 281.05 m/z, respectively. Dimeric ions [2M + H]+ and [2M + Na]+ are indicated at 517.14 and 539.12 m/z, respectively. The inset shows a zoom of the region of
the spectrum containing the dimer ions. A significant number of unassigned
background ions are observed in the spectrum due to contamination
of the flow path.
TOF-MS dimension of a
single pass cyclic IMS experiment of racemic
thalidomide. The major ions of interest are indicated on the spectrum,
the predominant species being the [M + H]+ and [M + Na]+ at 259.07 and 281.05 m/z, respectively. Dimeric ions [2M + H]+ and [2M + Na]+ are indicated at 517.14 and 539.12 m/z, respectively. The inset shows a zoom of the region of
the spectrum containing the dimer ions. A significant number of unassigned
background ions are observed in the spectrum due to contamination
of the flow path.We performed multipass
cIMS on the monomeric species at 259 and
281 m/z, the [M + H]+ and [M + Na]+, respectively. In line with expectations,
no separation of species was observed, and the arrival time distributions
(ATDs) obtained as well as the TWCCN2 values
were identical between rac-thalidomide and (R)- and (S)-thalidomide (Figure S1).Next, we conducted cIMS experiments on the
dimeric [2M + H]+ and [2M + Na]+ ions observed
at 517 m/z and 539 m/z in the rac-thalidomide sample,
respectively. Both
ion populations exhibited only a single species in their ATDs after
1 cIMS pass (Figure S2). After 5 cIMS passes
(Rp ∼ 145 CCS/ΔCCS), the
[2M + H]+ yielded two well-resolved features (Figure A,iii), suggesting
two distinct forms of dimer. Going forward, we refer to these as features
1 and 2. The [2M + Na]+ ions showed similar behavior albeit
after 10 cIMS passes ion (Rp ∼
200 CCS/ΔCCS) (Figure B,iii), which could be baseline separated after 20 passes
(Figure S2C). The TWCCSN2 values for the dimer features were measured as 220 and 225
Å2 for the [2M + H]+ and 226 and 229 Å2 for [2M + Na]+, with differences of 2.2 and 1.3%,
respectively. Interestingly, we also observed the same behavior for
the lithium-adducted dimers of thal, [2M + Li]+, where
two features were detected in the ATD of the racemic mixture, albeit
with a lesser degree of separation after 10 passes (Figure S3).
Figure 3
Multipass cIMS of dimeric thalidomide ions. (A) Five pass
ATD of
the [2M + H]+ ion of (i) (R)-thal, (ii)
(S)-thal, and (iii) rac-thal. (B)
Ten pass ATDs of the [2M + Na]+ ion of (i) (R)-thal, (ii) (S)-thal, and (iii) rac-thal. In both cases, rac-thal exhibits two features
(1 and 2), albeit in different ratios. (R)-Thal displays
overwhelmingly feature 1, whereas (S)-thal displays
predominantly feature 1 and a small proportion of feature 2. The data
are consistent with the formation of diastereomeric pairs of enantiomers.
Multipass cIMS of dimeric thalidomide ions. (A) Five pass
ATD of
the [2M + H]+ ion of (i) (R)-thal, (ii)
(S)-thal, and (iii) rac-thal. (B)
Ten pass ATDs of the [2M + Na]+ ion of (i) (R)-thal, (ii) (S)-thal, and (iii) rac-thal. In both cases, rac-thal exhibits two features
(1 and 2), albeit in different ratios. (R)-Thal displays
overwhelmingly feature 1, whereas (S)-thal displays
predominantly feature 1 and a small proportion of feature 2. The data
are consistent with the formation of diastereomeric pairs of enantiomers.The presence of two features in the dimeric ATDs
implies either
protomers or inherently different structures, which in this case could
mean diastereomeric dimers. If the latter case is true, in the rac-thal sample there is the possibility of forming (R,R) and (S,S) homodimers, as well as (R,S)
and (S,R) heterodimers (Figure B). The (R,R) and (S,S) homodimers are one enantiomer pair and the (R,S) and (S,R) heterodimers
are another, with those pairs being diastereomers of each other. If
the propensities of dimer formation are not drastically different
for each pair, then this would give rise to two features in the ATD,
one for (R,R)/(S,S) and another for (R,S)/(S,R), provided the
pairs can be separated by their mobilities. Note that no separation
can be achieved within each pair, as these are enantiomers.To determine the identity of each feature, we next infused separate
solutions of “pure” (R)- and (S)-thal and subjected them to the same experimental conditions.
For both (R)-thal (Figure A,i and B,i) and (S)-thal
(Figure A,ii and B,ii),
only a single major feature was observed in each case as expected,
and their arrival times were consistent only with feature 1 from rac-thal (Figure A,iii and B,iii). This supports the conclusion that feature
1 is the homodimer signal, (R,R)
in the case of (R)-thal, (S,S) in the case of (S)-thal, and both (R,R) and (S,S) in rac-thal. Only a small indication of feature
2 was observed in the case of both protonated and sodiated (S)-thal (Figure A,ii and B,ii). The presence of feature 2 predominantly in
the rac-thal sample leads us to conclude that this
is indeed due to the (R,S)/(S,R) heterodimers that, being diastereomers
of (R,R)/(S,S), are able to be separated from feature 1. Again, a similar
behavior was observed for the lithiated dimers (Figure S3)As an aside, during optimization of the experimental
conditions,
we noticed dissociation of dimeric ions into monomers postmobility
(Figure S4). The instrument was tuned to
minimize this effect, but we think it worth mentioning that if the
instrument was particularly harsh, yielding only monomeric ions, it
might lead to misinterpretation of the monomeric ATD as containing
more than one feature, that is, as a result of retaining the mobility
information of the dimeric precursors.Returning to the dimers,
a key observation in these data is the
presence of feature 2 at detectable levels in both protonated and
sodiated (S)-thal (Figures A,ii and B,ii). This indicates that (S)-thal is not pure, as there is sufficient (R)-thal present in solution to yield (R,S)/(S,R) heterodimers. The same
is not true of the (R)-thal sample, which has no
significant amount of the heterodimers present. This result highlights
the utility of this method in providing a fast readout of the optical
purity status (pure vs impure) of this chiral compound.
Quantifying
Enantiomeric Composition
To explore the
dimerization phenomenon further we performed the multipass cIMS experiment
on mixtures of (R)- and (S)-thalidomide
in ratios 50:1, 20:1, 10:1, 1:1, 1:2, 1:10, 1:20, and 1:50. In this
experiment we focused on the [2M + Na]+ ions due to their
greater relative intensity in the mass spectrum and greater perceived
stability. It can be seen in Figure A that, as the ratio of (R)-thal to
(S)-thal is increased from 1:1 to 2:1, the relative
intensity of feature 2 decreases. This trend is borne out as the ratio
is increased further to 10:1, 20:1, and 50:1. Increasing the ratio
in the opposite direction from 1:1 to 1:2 (R)/(S) exhibits similar behavior to 2:1 (R)/(S), and likewise for the rest of the mixing ratios where
(S) is in excess. The reason for the reduced intensity
of feature 2 as the enantiomer ratio deviates from 1:1 is the reduction
in the relative mole fraction of the minor enantiomer available for
heterodimer formation, meaning homodimers become more likely.
Figure 4
Effect of the
enantiomer ratio on the observed dimer peak areas
for thalidomide [2M + Na]+. (A) Arrival time distributions
from 10 pass cIMS experiments, where the ratio of enantiomers was
varied. At 50:1 (R)/(S), the relative
peak area of feature 2 is low. As the amount of (S)-thal is increased, the relative peak area of feature 2 increases
to a maximum at 1:1 (R)/(S) (red
trace). As the amount of (S)-thal is increased further,
feature two begins to decrease in intensity once more to a minimum
at 50:1 (S)/(R). (B) Relative peak
areas of feature 1 (P1) and feature 2 (P2) as a function of the enantiomer
ratio. Red solid line, (R)/(S) P1;
red dashed line, (R)/(S) P2; gray
solid line, (S)/(R) P1; gray dashed
line, (S)/(R) P2; black solid line
and dashed line, the “simplistic” case should the dimers
have the same association energy for P1 and P2, respectively; blue
solid line and dashed line, the empirically F-adjusted
“simplistic” case based on the ratios observed in the
racemate P1 and P2, respectively. There is good agreement between
the F-adjusted simplistic case and experiment.
Effect of the
enantiomer ratio on the observed dimer peak areas
for thalidomide [2M + Na]+. (A) Arrival time distributions
from 10 pass cIMS experiments, where the ratio of enantiomers was
varied. At 50:1 (R)/(S), the relative
peak area of feature 2 is low. As the amount of (S)-thal is increased, the relative peak area of feature 2 increases
to a maximum at 1:1 (R)/(S) (red
trace). As the amount of (S)-thal is increased further,
feature two begins to decrease in intensity once more to a minimum
at 50:1 (S)/(R). (B) Relative peak
areas of feature 1 (P1) and feature 2 (P2) as a function of the enantiomer
ratio. Red solid line, (R)/(S) P1;
red dashed line, (R)/(S) P2; gray
solid line, (S)/(R) P1; gray dashed
line, (S)/(R) P2; black solid line
and dashed line, the “simplistic” case should the dimers
have the same association energy for P1 and P2, respectively; blue
solid line and dashed line, the empirically F-adjusted
“simplistic” case based on the ratios observed in the
racemate P1 and P2, respectively. There is good agreement between
the F-adjusted simplistic case and experiment.The relative peak areas were extracted by Gaussian
fitting to the
ATDs and plotted in Figure B. The plot reveals the increase in the relative area of feature
1 and the concomitant decrease in the area of feature 2. It was expected
that the curve for the increase in (R)-thal (red
lines) would be identical to that of (S)-thal (gray
lines); however, significant differences are observed. The trend on
increasing the proportion of (S)-thal from 1:1 (S)/(R) to 2:1 (S)/(R), for example, is steeper than when increasing the proportion
of (R)-thal in the same way. This could be attributed
to the fact that the (S)-thal sample already contains
a significant amount of (R)-thal, as seen in Figure A,ii and B,ii. Despite
this, the observed variation in relative peak area with enantiomer
ratio reveals a second advantage of this method in that it is quantitative.
The enantiomer ratio can be determined from performing this experiment
on a sample containing an unknown ratio of (R)- and
(S)-thalidomide. However, with this significant finding,
a major caveat is revealed; the ratio of enantiomers can be determined,
but the experiment does not reveal directly which enantiomer is indeed
in excess. Some a priori knowledge of which enantiomer is in excess,
akin to the above example of the (S)-thal sample,
is required in order to draw conclusions on absolute enantiomer composition.
However, as will be discussed below, given the appropriate pure standards
the predominant enantiomer can be identified indirectly.
Adjusting for
Differences in Dimer Stability
The data
in Figures and 4 exhibit in all cases a relative peak area for feature
2 that is much less than feature 1, even where the enantiomer ratio
is 1:1. This suggests that the heterodimers of thal are significantly
less stable than the homodimers, either by virtue of the mechanism
of formation during electrospray or by their susceptibility to dissociate
at various stages during transfer through the instrument. For this
method to be quantitative, this observation must be accounted for. Figure B shows a theoretical
curve for the variation of relative peak areas of features 1 and 2
with enantiomer ratio given the “simplistic” theoretical
case where the stability of the homo- and heterodimers are identical
(black lines). This case would yield a 1:1 peak area ratio given a
1:1 mixture of (R)- and (S)-thal,
which would increase according to the relative concentration of each
enantiomer. In reality, the data themselves do not follow this simplistic
case, so the relative stabilities of the dimers can be accounted for
by a “response factor”, which we have called F, for the heterodimer peak based on that observed in the
racemic mixture, that is, knowing the empirical peak area ratios in
the 1:1 condition, we can predict the peak areas for all other enantiomer
ratios (dark blue lines in Figure B) and use this to determine the enantiomer ratio in
an unknown mixture. This “F-adjusted simplistic”
curve in Figure B
(dark blue lines) shows good agreement with the experimental curves,
indicating that it is a good approximation of the data.The
method presented here relies on the a priori knowledge of the “response
factor”, F, however, we note that such knowledge
is not unprecedented in the study of enantiomer composition. Indeed,
when determining the optical purity of a particular chiral compound
using circularly polarized light, experimenters require a priori knowledge
of the specific rotation of a pure enantiomer to obtain meaningful
information. We suggest that F, in the case of the
method presented here, be used in a similar way.The above quantification
method enables us to return to the supposedly
“pure” (S)-thal ATD in Figure A,ii and B,ii. The quoted purity
of this sample of (S)-thal from the manufacturer
is >98%. Measuring the relative peak areas of features 1 and 2
for
(S)-thal gives values of 96% and 4%, respectively.
Applying the appropriate F value gives an enantiomer
concentration ratio of approximately 50:1 (S)/(R), which is in excellent agreement with the quoted purity
boundary of >98%.
Applicability to Other Chiral Systems
To assess the
generality of the method, we next performed similar multipass cIMS
experiments on the chiral compounds d/l-tryptophan
(tryp) [2M + H]+ and (R)/(S)-propanolol (prop) [2M + Na]+ (Figure , structures shown in Figure S5). For d/l-tryptophan, 25 cIMS
passes were performed yielding a mobility resolving power of approximately
325 ΔCCS/CCS. The arrival time distribution exhibited two partially
resolved features, suggesting the formation of homo- and heterodimers
in the same way as for thal. Performing the same experiments on isolated d- and l-tryp (Figure A,ii and iii) yielded identical single features for
the homodimers that align with the more mobile ion population (feature
1) in the d/l-tryp ATD. This indicates that this
is the homodimer and feature 2 is the heterodimer. For rac-prop, 40 cIMS passes were performed to gain partial separation of
the dimer ions, corresponding to a mobility resolving power of 411
CCS/ΔCCS, a capability we believe is beyond any other commercial
ion mobility system. Once more, performing the same experiment on
isolated (R)- and (S)-prop yielded
a single feature, however, this time it aligned with the less mobile
population in the rac-prop ATD, indicating that in
this case the homodimer ions have the greater CCS. While it is not
surprising that the order of ion mobilities for dimeric ions observed
using this method is not fixed, it does highlight that this method
might be used to interrogate in greater detail the structures of the
dimer ions alongside computational approaches.
Figure 5
Dimerization phenomenon
in other chiral systems. (A) Arrival time
distributions of tryptophan [2M + H]+. (i) racemic d/l-tryp exhibits two features separated after 25 cIMS
passes (R ∼ 325 CCS/ΔCCS); (ii) d-tryp exhibits a single feature as does (iii) l-tryp,
indicating that the more mobile ions are the homodimers. (B) Arrival
time distributions of the [2M + Na]+ ion of propranolol.
(i) rac-Propanolol displays two features separated
after 40 cIMS passes (R ∼ 411 ΔCCS/CCS),
consistent with a homo- and heterodimer; (ii) (R)-prop
exhibits a single feature, as does (iii) (S)-prop,
indicating that the less mobile ions are the homodimers. For the ATDs
of d/l-tryp and rac-prop, the Gaussian
fits for the homodimers (blue) and heterodimers (red) are shown (A,i
and B,i).
Dimerization phenomenon
in other chiral systems. (A) Arrival time
distributions of tryptophan [2M + H]+. (i) racemic d/l-tryp exhibits two features separated after 25 cIMS
passes (R ∼ 325 CCS/ΔCCS); (ii) d-tryp exhibits a single feature as does (iii) l-tryp,
indicating that the more mobile ions are the homodimers. (B) Arrival
time distributions of the [2M + Na]+ ion of propranolol.
(i) rac-Propanolol displays two features separated
after 40 cIMS passes (R ∼ 411 ΔCCS/CCS),
consistent with a homo- and heterodimer; (ii) (R)-prop
exhibits a single feature, as does (iii) (S)-prop,
indicating that the less mobile ions are the homodimers. For the ATDs
of d/l-tryp and rac-prop, the Gaussian
fits for the homodimers (blue) and heterodimers (red) are shown (A,i
and B,i).Inspecting the ATDs for d/l-tryp and rac-prop, we also notice that
the relative intensities of
features 1 and 2 in the ATDs of both tryptophan and propranolol in
the 1:1 condition (Figure A,i and B,i) indicate that their homo- and heterodimer association
energies are more similar than for thal. This indicates a value of F closer to 1 for both of these systems.Perturbation
of the ratios of the d/l-tryp and
(R)/(S)-prop enantiomers revealed
the dependence of enantiomer composition on the relative areas of
the two features (Figure S6), indicating
that, in the same way as for thal, these ratios can be used to determine
enantiomer composition, given the appropriate prior information. For
both tryptophan and propranolol, Gaussian peak fitting was performed
to determine the relative peak areas. For each, the empirical F value was determined from the 1:1 condition and applied
to the other ratios, and excellent agreement was observed between
the corresponding “F-adjusted simplistic”
curves and the experimental data (Figure S7).A further example of the dimerization phenomenon was found
in penicillamine
(Figure S5) that, rather than forming noncovalent
electrospray-mediated dimers, forms spontaneous disulfide-linked dimers.
Performing a 10 pass cIMS experiment on the d/l-penicillamine
mixture yielded two features, with only one in the isolated d- and l-forms (Figure S8). While
this provides an additional example of separating pairs of diastereomeric
pairs of enantiomeric dimers, it may be more difficult to probe relative
enantiomer ratios in this case due to the predominance of irreversible
covalent dimer formation.
Determining Enantiomer Identity
It is worth discussing
that this method may be used to determine which enantiomer is present
in excess in a sample, albeit indirectly, by performing a titration,
given that sample is nonracemic. Imagine a pure enantiomer of unknown
identity, where the experimental homodimer ion mobility trace exhibits
a single peak, as in Figure A and B,i,ii. Should the user have a pure standard available
of either enantiomer, two mixtures, one of the unknown with the (R) enantiomer and one with the (S) enantiomer,
can be prepared. If the unknown is actually the (R) enantiomer, after mixing with the (R) enantiomer
the ion mobility trace will not change (Figure , top). In the case of mixing with the (S) enantiomer the ion mobility trace will exhibit a second
peak similar to feature 2 in the above data (Figure A,ii and B,ii). The same is true if the unknown
sample is not completely pure. If more (S) is added,
the intensity of the heterodimer peak will increase, if more (R) is added the intensity of the homodimer peak will increase
(Figure , bottom).
Hence, the approach has a third key utility, determining which enantiomer
is in excess. It should be noted, however, that when probing a near
racemic mixture with this titration experiment care must be taken
not to “overshoot” the racemate as this could lead to
misleading results.
Figure 6
Summary of the method. Scenario 1 (top), where the experimenter
is faced with a single feature in the ATD. If, for example, some pure
(R) enantiomer is added, the ATD appearance will
not change and would identify the starting substance as (R). If (S) is added, however, a second heterodimer
feature will appear, supporting the conclusion that the starting substance
is (R). The converse is true of the pure (S) enantiomer. Scenario 2 (bottom), where a bimodal distribution
is observed. Adding (R) will increase the relative
peak area of feature 1 and decrease feature 2. Adding (S) will increase the relative area of feature 2. Both these observations
would identify (R) as being in excess. The original
ATD can be used to quantify the enantiomer composition.
Summary of the method. Scenario 1 (top), where the experimenter
is faced with a single feature in the ATD. If, for example, some pure
(R) enantiomer is added, the ATD appearance will
not change and would identify the starting substance as (R). If (S) is added, however, a second heterodimer
feature will appear, supporting the conclusion that the starting substance
is (R). The converse is true of the pure (S) enantiomer. Scenario 2 (bottom), where a bimodal distribution
is observed. Adding (R) will increase the relative
peak area of feature 1 and decrease feature 2. Adding (S) will increase the relative area of feature 2. Both these observations
would identify (R) as being in excess. The original
ATD can be used to quantify the enantiomer composition.
Conclusions
The characterization of chiral systems
is a significant challenge
in analytical chemistry, and faster and more informative techniques
are required to serve the chemical and life science fields. Separation
of enantiomers by imposing a diastereomeric character either covalently
or noncovalently requires specific and nonuniversal derivatizing agents
or cofactors as chiral modifiers. We have presented here a simple
and rapid approach to the determination of the enantiomeric composition
of chiral compounds without the need for any chiral modifier. We have
shown that by forming diastereomeric pairs of enantiomeric dimers
and separating them by high resolution cyclic ion mobility–mass
spectrometry, we can determine the purity status and the enantiomer
ratio and, given the appropriate available pure materials, we can
determine the identity of the major and minor components in an enantiomer
mixture. We believe this approach will be highly valuable in particular
in the pharmaceutical industry where the in-depth knowledge of drug
substances is both a safety and an intellectual property concern.
Authors: David P Smith; Tom W Knapman; Iain Campuzano; Richard W Malham; Joshua T Berryman; Sheen E Radford; Alison E Ashcroft Journal: Eur J Mass Spectrom (Chichester) Date: 2009 Impact factor: 1.067
Authors: Sunnie Myung; Marco Fioroni; Ryan R Julian; Stormy L Koeniger; Mu-Hyun Baik; David E Clemmer Journal: J Am Chem Soc Date: 2006-08-23 Impact factor: 15.419
Authors: Gabe Nagy; Christopher D Chouinard; Isaac K Attah; Ian K Webb; Sandilya V B Garimella; Yehia M Ibrahim; Erin S Baker; Richard D Smith Journal: Electrophoresis Date: 2018-09-17 Impact factor: 3.535